On thursday, 15 february 2018 the 4th project meeting brought together the protagonists of the oraCle project to review and discuss the work progress. The meeting begun in the morning at the University of Udine, where each project partner presented the progress of work and the achieved results.There was no lack of useful moments of…
On 29th and 30th January 2018 two members of the Advisory Council of the ICCO (Italian Chamber of Commerce in Ontario) – Tenio EVANGELISTA of the Omers Venture (Investment sector) and Renato DISCENZA of the Azcendis (Life science / health sector) – went to visit Friuli Venezia Giulia, taking advantage of the opportunity to get…
The local and national press is talking about “oraCle: New integrated approach for the oral therapy of Crohn’s disease”. Many journals are spreading awareness towards this project. Here the press releases issued in the month of January, 2018. Diario di Udine 03 gennaio 2018 [ITA] Il Gazzettino.it 03 gennaio 2018 [ITA] Messaggero Veneto.it 03 gennaio 2018 [ITA] Messaggero…
On Friday, 17th November 2017 Transactiva’s staff took part in the conference “GDPR. Data security. Corporate secret.” held at PST “Luigi Danieli”, organized by Fill In The Blanks srl and in collaboration with D’Agostini Law Firm. On the occasion Transactiva has had the opportunity to introduce its reality to the participants, both during the convivial…
Transactiva and the University of Trieste were among the winners of the “Made in Trieste” call, aimed at promoting applied research projects in the field of Life Sciences, with the project “Production of human Brain-Derived Neurotrophic Factor (BDNF) in endosperm of Oryza sativa”. The projects, which will be developed by public-private partnerships, have been evaluated by…
The oraCle project is at the height of its activities. The scientific partners met at the University of Trieste, guests of the Department of Life Sciences, on October 12, 2017. For the purposes of a better and more effective sharing of the respective contributions, each partner has structured a presentation of its research activities, highlighting…
The oraCle project is proceeding well. The project partners met in the second meeting, held on 19 June 2017 at the Biofarma SpA headquarters. The meeting, focused on the scientific side of oraCle, saw a useful confrontation on the technical aspects and the definition of the planned activities for the coming months. On the agenda: Any…
MossTech: Advanced use of mosses for biotechnological solutions” is a project based on the Horizon 2020 call “H2020-MSCA-ITN-2017”, or “Marie Sklodowska-Curie Innovative Training Networks”, which provides for the training of 6 young researchers (Early Stage Researchers, ESRs) through industrial doctorate projects at European level (EID, European Industrial Doctorates). Each project involves the participation of a…
The “oraCle: New integrated approach to the oral therapy of Crohn’s Disease” project has officially started on April 1st, 2017. The first project meeting brought together industrial and public partners in the definition of strategies and action plans to follow in the coming months. The meeting, held at the “Luigi Danieli” Science and Technology Park…
In July 2017 Transactiva directed, as leader, a public-private partnership for the participation in the POR FESR 2014-2020 calls, (Activity 1.3.b) – for “R&D projects to be achieved through public-private partnerships – areas of specialization Maritime Technologies and Smart Health”. The project “A new integrated approach for oral therapy of Crohn’s disease: oraCle” was presented…
